Medmira (MMIRF, $0.05) was one of top quarterly gainers, jumping +31 to $0.05 per share. A.I.dvisor analyzed 817 stocks in the Biotechnology Industry over the last three months, and discovered that of them () charted an Uptrend while of them () trended down.